Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells

  • Authors:
    • Thae Hyun Kim
    • Ji Hye Park
    • Jae Suk Woo
  • View Affiliations

  • Published online on: February 15, 2019     https://doi.org/10.3892/mmr.2019.9962
  • Pages: 3353-3360
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Resveratrol, a natural polyphenol compound, has been reported to exert anticancer activity in various cancer cells. The present study investigated the effect and underlying mechanisms of resveratrol in the human ovarian cancer cell lines, A2780 and SKOV3. Treatment with resveratrol induced apoptotic cell death in dose‑ and time‑dependent manners, as well as a transient increase of reactive oxygen species (ROS) generation. Resveratrol‑induced cell death was attenuated by the antioxidant, N‑acetylcysteine (NAC), suggesting that ROS were involved in the observed cell death. Treatment with resveratrol resulted in a ROS‑dependent decrease of Notch1 signaling. When cells were transfected to overexpress Notch1 using EF.hlCN1.CMV.GFP, resveratrol‑induced cell death was blocked. Western blot analysis demonstrated that resveratrol also upregulated phospho‑phosphatase and tensin homolog (p‑PTEN) and downregulated phospho‑Akt (p‑Akt). Overexpression of p‑Akt by transfection with a constitutively active form (caAkt), and the p‑PTEN inhibitor SF1670 prevented resveratrol‑induced cell death. The caspase‑3 inhibitor z‑DEVD‑FMK significantly attenuated the resveratrol‑induced caspase‑3 cleavage. Taken together, the results of the present study suggest that resveratrol induces caspase‑dependent cell death through suppression of Notch1 and PTEN/Akt signaling and it is mediated by increased ROS generation in human ovarian cancer cells.

References

1 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Hansen JM, Coleman RL and Sood AK: Targeting the tumour microenvironment in ovarian cancer. Eur J Cancer. 56:131–143. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH and Lee KH; Community of Population-Based Regional Cancer Registries, : Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 49:292–305. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Smoliga JM, Baur JA and Hausenblas HA: Resveratrol and health-a comprehensive review of human clinical trials. Mol Nutr Food Res. 55:1129–1141. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Riba A, Deres L, Sumegi B, Toth K, Szabados E and Halmosi R: Cardioprotective effect of resveratrol in a postinfarction heart failure model. Oxid Med Cell Longev. 2017:68192812017. View Article : Google Scholar : PubMed/NCBI

6 

Chatterjee A, Ronghe A, Padhye SB, Spade DA, Bhat NK and Bhat HK: Antioxidant activities of novel resveratrol analogs in breast cancer. J Biochem Mol Toxicol. 322018.

7 

Singh SK, Banerjee S, Acosta EP, Lillard JW and Singh R: Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget. 8:17216–17228. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Wang X, Wang D and Zhao Y: Effect and mechanism of resveratrol on the apoptosis of lung adenocarcinoma cell line A549. Cell Biochem Biophys. 73:527–531. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Gong WH, Zhao N, Zhang ZM, Zhang YX, Yan L and Li JB: The inhibitory effect of resveratrol on COX-2 expression in human colorectal cancer: A promising therapeutic strategy. Eur Rev Med Pharmacol Sci. 21:1136–1143. 2017.PubMed/NCBI

10 

Alobaedi OH, Talib WH and Basheti IA: Antitumor effect of thymoquinone combined with resveratrol on mice transplanted with breast cancer. Asian Pac J Trop Med. 10:400–408. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Li P, Xu J, Wu X, Wu X, Guo Z, Fan L, Song R, Wang J, Wei L and Teng H: Resveratrol attenuates high glucose-induced nucleus pulposus cell apoptosis and senescence through activating the ROS-mediated PI3K/Akt pathway. Biosci Rep. 38(pii): BSR201714542018.PubMed/NCBI

12 

Hui Y, Chengyong T, Cheng L, Haixia H, Yuanda Z and Weihua Y: Resveratrol attenuates the cytotoxicity induced by amyloid-β1–42 in PC12 cells by upregulating heme oxygenase-1 via the PI3K/Akt/Nrf2 pathway. Neurochem Res. 43:297–305. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Hou Y, Feng S, Wang L, Zhao Z, Su J, Yin X, Zheng N, Zhou X, Xia J and Wang Z: Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma cells. Oncotarget. 8:62120–62130. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Zhang L, Sha J, Yang G, Huang X, Bo J and Huang Y: Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells. Cell Cycle. 16:999–1007. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Bertelli AA and Das DK: Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol. 54:468–476. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Piotrowska H, Myszkowski K, Ziolkowska A, Kulcenty K, Wierzchowski M, Kaczmarek M, Murias M, Kwiatkowska-Borowczyk E and Jodynis-Liebert J: Resveratrol analogue 3,4,4′,5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells. Toxicol Appl Pharmacol. 263:53–60. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Vergara D, De Domenico S, Tinelli A, Stanca E, Del Mercato LL, Giudetti AM, Simeone P, Guazzelli N, Lessi M, Manzini C, et al: Anticancer effects of novel resveratrol analogues on human ovarian cancer cells. Mol Biosyst. 13:1131–1141. 2017. View Article : Google Scholar : PubMed/NCBI

18 

Seino M, Okada M, Shibuya K, Seino S, Suzuki S, Takeda H, Ohta T, Kurachi H and Kitanaka C: Differential contribution of ROS to resveratrol-induced cell death and loss of self-renewal capacity of ovarian cancer stem cells. Anticancer Res. 35:85–96. 2015.PubMed/NCBI

19 

Sena LA and Chandel NS: Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 48:158–167. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Xia N, Daiber A, Förstermann U and Li H: Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol. 174:1633–1646. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Heiss EH, Schilder YD and Dirsch VM: Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J Biol Chem. 282:26759–26766. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Schilder YD, Heiss EH, Schachner D, Ziegler J, Reznicek G, Sorescu D and Dirsch VM: NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radic Biol Med. 46:1598–1606. 2009. View Article : Google Scholar : PubMed/NCBI

23 

de la Lastra CA and Villegas I: Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications. Biochem Soc Trans. 35:1156–1160. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Lang F, Qin Z, Li F, Zhang H, Fang Z and Hao E: Apoptotic cell death induced by resveratrol is partially mediated by the autophagy pathway in human ovarian cancer cells. PLoS One. 10:e01291962015. View Article : Google Scholar : PubMed/NCBI

25 

Zhang P, Li H, Yang B, Yang F, Zhang LL, Kong QY, Chen XY, Wu ML and Liu J: Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes Cancer. 5:154–164. 2014.PubMed/NCBI

26 

Zheng XJ, Yang ZX, Dong YJ, Zhang GY, Sun MF, An XK, Pan LH and Zhang SL: Downregulation of leptin inhibits growth and induces apoptosis of lung cancer cells via the Notch and JAK/STAT3 signaling pathways. Biol Open. 5:794–800. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Kim SY, Kim MY, Mo JS and Park HS: Notch1 intracellular domain suppresses APP intracellular domain-Tip60-Fe65 complex mediated signaling through physical interaction. Biochim Biophys Acta. 1773:736–746. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Coant N, Ben Mkaddem S, Pedruzzi E, Guichard C, Tréton X, Ducroc R, Freund JN, Cazals-Hatem D, Bouhnik Y, Woerther PL, et al: NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol. 30:2636–2650. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC, et al: Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY). 3:192–222. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Yang Z, Liu Y, Shi C, Zhang Y, Lv R, Zhang R, Wang Q and Wang Y: Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways. Oncol Rep. 37:1011–1019. 2017. View Article : Google Scholar : PubMed/NCBI

31 

Rana C, Piplani H, Vaish V, Nehru B and Sanyal SN: Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by diclofenac and curcumin in colon cancer. Mol Cell Biochem. 402:225–241. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Kim DH, Kim MJ, Sung B, Suh H, Jung JH, Chung HY and Kim ND: Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells. Oncol Rep. 37:281–288. 2017. View Article : Google Scholar : PubMed/NCBI

33 

Guo D, Teng Q and Ji C: NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia. Leuk Lymphoma. 52:1200–1210. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Cornejo MG, Mabialah V, Sykes SM, Khandan T, Lo Celso C, Lopez CK, Rivera-Muñoz P, Rameau P, Tothova Z, Aster JC, et al: Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification. Blood. 118:1264–1273. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Wang L, Jin F, Qin A, Hao Y, Dong Y, Ge S and Dai K: Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family. Mol Cancer. 13:1392014. View Article : Google Scholar : PubMed/NCBI

36 

Zhang L, Lei J, Liu J, Ma F and Ju H: In situ activation and monitoring of the evolution of the intracellular caspase family. Chem Sci. 6:3365–3372. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Mondal A and Bennett LL: Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage. Biomed Pharmacother. 84:1906–1914. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2019
Volume 19 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Kim, T.H., Park, J.H., & Woo, J.S. (2019). Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells. Molecular Medicine Reports, 19, 3353-3360. https://doi.org/10.3892/mmr.2019.9962
MLA
Kim, T. H., Park, J. H., Woo, J. S."Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells". Molecular Medicine Reports 19.4 (2019): 3353-3360.
Chicago
Kim, T. H., Park, J. H., Woo, J. S."Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells". Molecular Medicine Reports 19, no. 4 (2019): 3353-3360. https://doi.org/10.3892/mmr.2019.9962